Deutsche Bank’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-69,630
| Closed | -$9.75M | – | 5626 |
|
|
2018
Q4 | $9.75M | Sell |
69,630
-203,849
| -75% | -$30.9M | 0.01% | 1320 |
|
|
2018
Q3 | $46.7M | Buy |
273,479
+95,930
| +54% | +$16.1M | 0.02% | 679 |
|
|
2018
Q2 | $30.8M | Sell |
177,549
-19,170
| -10% | -$2.88M | 0.02% | 917 |
|
|
2018
Q1 | $22.7M | Buy |
196,719
+68,050
| +53% | +$7.24M | 0.01% | 1032 |
|
|
2017
Q4 | $10.8M | Sell |
128,669
-49,022
| -28% | -$4.09M | 0.01% | 1438 |
|
|
2017
Q3 | $16.4M | Buy |
177,691
+124,383
| +233% | +$9.66M | 0.01% | 1157 |
|
|
2017
Q2 | $4.27M | Buy |
53,308
+17,266
| +48% | +$957K | ﹤0.01% | 2032 |
|
|
2017
Q1 | $1.51M | Buy |
36,042
+15,982
| +80% | +$658K | ﹤0.01% | 2406 |
|
|
2016
Q4 | $642K | Buy |
20,060
+3,140
| +19% | +$80.5K | ﹤0.01% | 3022 |
|
|
2016
Q3 | $440K | Buy |
16,920
+4,155
| +33% | +$109K | ﹤0.01% | 3267 |
|
|
2016
Q2 | $294K | Buy |
12,765
+3,042
| +31% | +$75.7K | ﹤0.01% | 3566 |
|
|
2016
Q1 | $264K | Sell |
9,723
-21,043
| -68% | -$440K | ﹤0.01% | 3524 |
|
|
2015
Q4 | $873K | Sell |
30,766
-15,402
| -33% | -$413K | ﹤0.01% | 2965 |
|
|
2015
Q3 | $806K | Buy |
46,168
+43,884
| +1,921% | +$859K | ﹤0.01% | 3084 |
|
|
2015
Q2 | $39K | Buy |
2,284
+2,083
| +1,036% | +$28.5K | ﹤0.01% | 4694 |
|
|
2015
Q1 | $2K | Sell |
201
-12,514
| -98% | -$156K | ﹤0.01% | 5001 |
|
|
2014
Q4 | $149K | Buy |
12,715
+3,705
| +41% | +$43.2K | ﹤0.01% | 4464 |
|
|
2014
Q3 | $118K | Buy |
+9,010
| New | +$117K | ﹤0.01% | 4413 |
|
Other funds holding LOXO
Deutsche Bank's LOXO Position: Q1 2019 in Review
Deutsche Bank sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 69,630 shares — an estimated $9.75M sold.
Deutsche Bank first reported a position in LOXO in Q3 2014 and held it in 18 quarters. The position peaked at $46.7M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Deutsche Bank reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Deutsche Bank sold 69,630 Loxo Oncology, Inc shares in Q1 2019, an estimated $9.75M.
- Deutsche Bank first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 18 quarters.
- Deutsche Bank's Loxo Oncology, Inc position peaked at $46.7M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Deutsche Bank's 13F filing for Q1 2019, filed 15 May 2019.